Brent McCarty, MD
Hand Surgery · Covington, LANPI 1487949483
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (40.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by ALON Medical Technology at 37.5% of the total. Reporting peaked in 2019 at $4,224 and has fallen 97.9% since, to $90 in 2025.
Across 70 payments — averaging $100.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ALON Medical Technology$3K
- Arthrex$3K
- Axogen$636
- Johnson & Johnson$248
- Amgen$229
- Stryker$155
- plus $527 from 7 others
What the payments were for
- Travel & lodging$2,20731%
- Food & beverage$2,01329%
- Education$2,84040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ALON Medical Technology | 15 | $2,646 |
| Arthrex | 16 | $2,619 |
| Axogen | 2 | $636 |
| Johnson & Johnson | 3 | $248 |
| Amgen(2 entities) | 10 | $229 |
| Stryker | 5 | $155 |
| Smith+Nephew | 3 | $152 |
| Endo Pharmaceuticals Inc. | 7 | $114 |
| Integra Lifesciences Corporation | 2 | $92 |
| Anika Therapeutics, Inc. | 1 | $66 |
| Endo USA, Inc. | 3 | $53 |
| Pacira Therapeutics, Inc. | 2 | $31 |
| Dynasplint Systems Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,060 in reported general payments places this provider in the 70th percentile of 29 hand surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 177 | $1,134 |
| Meloxicam | 71 | $331 |
| Celecoxib | 32 | $315 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $296 |
| Methylprednisolone | 45 | $279 |
| Tizanidine Hcl | 13 | $170 |
| Gabapentin | 24 | $147 |
| Tramadol Hcl | 26 | $141 |
| Ibuprofen | 12 | $103 |
| Cefadroxil | 11 | $62 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $37 |
| Amitriptyline Hcl | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Covington
- Richard CelentanoCovington$2K
- Leslie SiscoNew Orleans$169K
- Mark DodsonAlexandria$28K
- Ryan BlissBaton Rouge$11K
- Diego MirandaBossier City$10K
- Nicholas PappasMetairie$9K
- Cameron BestMonroe$8K
- Brandon DonnellyMetairie$8K
- Sagar ShahLafayette$7K
- Ross DunbarNew Orleans$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.